Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme

Documenti analoghi

• EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
  di: Laurenzana, Anna, et al.
  Pubblicazione: (2019)
• uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
  di: Biagioni, Alessio, et al.
  Pubblicazione: (2020)
• CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
  di: Biagioni, Alessio, et al.
  Pubblicazione: (2021)
• The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
  di: Margheri, Francesca, et al.
  Pubblicazione: (2014)
• uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines
  di: Biagioni, Alessio, et al.
  Pubblicazione: (2020)